AF-353 hydrochloride

AF-353 hydrochloride
Please request pricing for this article.
Request Pricing

Item number Size Datasheet Manual SDS Delivery time Quantity Price
TGM-T85192-10mg 10 mg

7 - 10 business days*

-
TGM-T85192-50mg 50 mg

7 - 10 business days*

-
 
Description: This novel compound is an orally bioavailable antagonist of P2X3/P2X2/3 receptors,... more
Product information "AF-353 hydrochloride"
Description: This novel compound is an orally bioavailable antagonist of P2X3/P2X2/3 receptors, exhibiting potent activity with a pIC50 of 8 in both human and rat, and a pIC50 of 7.3 specifically for the human P2X2/3 receptor. It demonstrates high brain penetration, evidenced by a brain to plasma ratio of 6, and effectively blocks agonist-evoked intracellular Ca2+ flux and inward currents within the nanomolar range (10 nM to 1 µM) in cell lines that express human P2X3 and P2X2/3 receptors recombinantly. The compound also shows favorable pharmacokinetic properties, with a half-life (t1/2) of 1.63 hours and a time to reach maximum concentration (Tmax) of 30 minutes. Target: Others. Smiles: O(C1=C(C(C)C)C=C(OC)C(I)=C1)C=2C(N)=NC(N)=NC2.Cl
Keywords: P2X3 Purinergic Receptor Antagonist, AF353, P2X2/3 Purinergic Receptor Antagonist, AF353
Supplier: TargetMol
Supplier-Nr: T85192

Properties

Application: P2X3 receptor antagonist
MW: 436.68 D
Formula: C14H17IN4O2?HCl

Database Information

CAS : 927887-18-1| Matching products
KEGG ID : K05217 | Matching products

Handling & Safety

Storage: -20°C
Shipping: +4°C (International: +4°C)
Caution
Our products are for laboratory research use only: Not for administration to humans!
Information about the product reference will follow. more
You will get a certificate here
or to request a certificate of analysis.
Read, write and discuss reviews... more
Customer review for "AF-353 hydrochloride"
Write a review
or to review a product.
Viewed